Skip to content

Dietary Histone Deacetylase Inhibitors (HDAC)

Dietary Histone Deacetylase (HDAC) Inhibitors

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01543074
Enrollment
23
Registered
2012-03-02
Start date
2013-02-28
Completion date
2013-12-31
Last updated
2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Histone Deacetylase (HDAC) Activity

Keywords

HDAC, histone acetylation, broccoli sprout extract, garlic oil, PBMCs

Brief summary

This pilot, three-week study will help scientists understand more about how the foods people eat can modify histone deacetylases, enzymes the body produces naturally. Broccoli sprout extract (BSE) and garlic oil are thought to modify these enzymes. The purpose of this study is to see if taking broccoli sprout extract alone, garlic oil alone, or broccoli sprout extract and garlic oil together, can decrease the action of histone deacetylase (HDAC) and turn on genes in white blood cells. There will be 80 people in this study.

Detailed description

Study participants attend a pre-study meeting either individually or with several other potential volunteers according to their preference. The study is described in detail and participants are given the opportunity to ask questions. If participants agree to participate, they will sign the consent form. Height and weight will be measured privately. Food diary forms will be distributed and taught how to use. A 4ml (1 tsp) blood sample will be drawn for a pre-study blood chemistry, CBC and thyroid tests. Samples for all clinical labs done during the study will be sent to Good Samaritan Hospital, a CLIA-certified laboratory, on a fee-for-service basis. The study MD will evaluate the lab results. If the tests are abnormal as determined by the study MD, the participant will be excluded from the study and advised to see their doctor for evaluation. Subjects will observe dietary restrictions starting one week before Day 1 of the study and continuing through Day 14 (total of 3 weeks). Dietary restrictions are listed on the last page of the diet recall forms. Women with negative urine pregnancy test on the morning of Day 1 will be enrolled in the study. About 20 ml fasting blood will be drawn on the morning of Day 1. Breakfast will be provided and 3 capsules given to swallow. (One capsule will be garlic oil or garlic oil placebo, the other two will be BSE or BSE placebo.) No eating or drinking (except water) until the next blood draws at 1,3 6 hours after breakfast. Participants will come to the study site for the next seven days to consume the standard breakfast and study capsules, or we may send the breakfast and study capsules home with participants for the weekend. Blood will be sampled immediately before breakfast on day 7 and again at 1, 3, 6, 24 and 48 hours later. We will provide a standardized lunch to all participants on Days 1 and 7. Additional blood draws will occur at the end of week 2 (i.e. on day 14 of the study). The study will end after 2 weeks. Participants will fill out a dietary recall form three random times during the study on two week days and one weekend day. Urine will be collected on the following schedule: Day 1, 0-3 hours, 3-6 hours, 6-12 hours,12-24 hours, 24-48 hours; Day 7, 0-3 hours, 3-6 hours, 6-12 hours, 12-24 hours, 24-48 hours. Total urine from each interval will be collected and pooled in separate containers. We will provide the proper containers for urine collection. Urine may be stored at room temperature.

Interventions

DIETARY_SUPPLEMENTBSE placebo

2 pills = 0 micromoles of Sulforaphane/day

DIETARY_SUPPLEMENTGarlic oil

1 pill = 30 mg garlic oil/day

DRUGBSE

2 pills = 200 micromoles of Sulforaphane/day

DIETARY_SUPPLEMENTGarlic Oil Placebo

1 pill = 0 mg garlic oil/day

Sponsors

Texas A&M University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* age: 20 and older * body mass index 19-30 kg/sq m * willingness to maintain normal exercise and activity patterns * willingness to avoid cruciferous vegetables and garlic and related foods (onion etc.) 1 week before and 2 weeks during the trial for a total of 3 weeks

Exclusion criteria

* tobacco use within the past three months * engaging in aerobic activity more than 6 hours per week * being vegetarian or having other restrictive dietary requirements * consuming \>3 alcoholic beverages/day or \>10 per week * having history of diabetes or uremia or other known metabolic disease * participating in another dietary study within the past three months * for women, being pregnant or breastfeeding * gastrointestinal diseases that could increase gut permeability, including Crohn's disease, ulcerative colitis, gastritis * taking dietary supplements other than those given in the study * abnormal liver function, CBC, or thyroid values * individuals taking any drug or medication, prescription or over the counter, including Isoniazid, Saquinavir, Warfarin, Cyclosporine, Acetaminophen, Oxazepam, medications used for HIV/ AIDS, blood clotting, birth control pills, fish oil and medications metabolized by CYPs (CYP1A2, CYP2E1 and CYP3A4) during the dosing period of 1 week and 48 h prior to and after dosing. Exceptions may be made by the study MD and the PI if in their opinion a medication will not interfere with the scientific validity of the study. The study MD will evaluate a medication on a case-by-case basis to determine that efficacy and safety are not adversely affected. * Individuals who are known to have problems with blood clotting or increased bleeding, including hemophiliacs or anyone recently undergoing or recovering from a surgical procedure. * soy or garlic allergy

Design outcomes

Primary

MeasureTime frameDescription
Cmax of Sulforaphane and Its Metabolites in BloodBefore breakfast (0 hours) and 1, 3 and 6 hours after breakfast & pills on Days 1 & 7, and before breakfast on Days 8, 9 and 14.The levels of Sulforaphane and its metabolites (combined) in blood was measured using Liquid Chromatrography-Mass Spectrometry (LC-MS) methods. Cmax (mean +/- SD) values are shown in the Outcome Measure Data Table.
Tmax of Sulforaphane and Its Metabolites in BloodBefore breakfast (0 hours) and 1, 3 and 6 hours after breakfast & pills on Days 1 & 7, and before breakfast on Days 8, 9 and 14.The levels of Sulforaphane and its metabolites (combined) in blood was measured using Liquid Chromatrography-Mass Spectrometry (LC-MS) methods. The time to achieve highest plasma concentration (Tmax) is shown in the Outcome Measure Data Table.

Secondary

MeasureTime frameDescription
Histone Acetylation6 hHistone acetylation was measured by immunoblotting the levels of acetylated histone H4K12 in the circulating peripheral blood mononuclear cells (PBMCs) of subjects who consumed either placebo, garlic oil, BSE, or BSE+garlic oil. The fold increase in acetylated histone H4K12 in the different groups is shown in the Outcome Measure Data Table.

Countries

United States

Participant flow

Recruitment details

34 Subjects consented for the study at the Linus Pauling Institute clinic, Corvallis, Oregon during the period February, 2013 to November, 2013. However, only 23 who qualified the criteria in the pre-screen blood tests were selected for the study.

Participants by arm

ArmCount
BSE Placebo & Garlic Oil Placebo
Two BSE placebo capsules and one garlic oil placebo capsule per day for seven days BSE placebo & garlic oil placebo: see arm description BSE & Garlic Oil: see arm description
5
Garlic Oil Plus BSE Placebo
one garlic oil capsule plus 2 BSE placebo capsules per day for seven days BSE placebo & garlic oil placebo: see arm description BSE plus garlic oil placebo: see arm description
7
BSE Plus Garlic Oil Placebo
two BSE capsules plus one garlic oil placebo capsule per day for seven days garlic oil plus BSE placebo: see arm description BSE & Garlic Oil: see arm description
5
BSE & Garlic Oil
two BSE and one garlic oil capsule per day for seven days garlic oil plus BSE placebo: see arm description BSE plus garlic oil placebo: see arm description
6
Total23

Baseline characteristics

CharacteristicBSE Placebo & Garlic Oil PlaceboGarlic Oil Plus BSE PlaceboBSE Plus Garlic Oil PlaceboBSE & Garlic OilTotal
Age, Continuous27.8 years
STANDARD_DEVIATION 14.1
29.9 years
STANDARD_DEVIATION 10.1
30.8 years
STANDARD_DEVIATION 17.2
33.7 years
STANDARD_DEVIATION 18.1
30 years
STANDARD_DEVIATION 14
Region of Enrollment
United States
5 participants7 participants5 participants6 participants23 participants
Sex: Female, Male
Female
4 Participants3 Participants4 Participants1 Participants12 Participants
Sex: Female, Male
Male
1 Participants4 Participants1 Participants5 Participants11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
0 / 51 / 73 / 51 / 6
serious
Total, serious adverse events
0 / 50 / 70 / 50 / 6

Outcome results

Primary

Cmax of Sulforaphane and Its Metabolites in Blood

The levels of Sulforaphane and its metabolites (combined) in blood was measured using Liquid Chromatrography-Mass Spectrometry (LC-MS) methods. Cmax (mean +/- SD) values are shown in the Outcome Measure Data Table.

Time frame: Before breakfast (0 hours) and 1, 3 and 6 hours after breakfast & pills on Days 1 & 7, and before breakfast on Days 8, 9 and 14.

ArmMeasureValue (MEAN)Dispersion
BSE Placebo & Garlic Oil PlaceboCmax of Sulforaphane and Its Metabolites in BloodNA micromoles/L
Garlic Oil Plus BSE PlaceboCmax of Sulforaphane and Its Metabolites in BloodNA micromoles/L
BSE Plus Garlic Oil PlaceboCmax of Sulforaphane and Its Metabolites in Blood0.92 micromoles/LStandard Deviation 0.15
BSE & Garlic OilCmax of Sulforaphane and Its Metabolites in Blood1.26 micromoles/LStandard Deviation 0.17
Primary

Tmax of Sulforaphane and Its Metabolites in Blood

The levels of Sulforaphane and its metabolites (combined) in blood was measured using Liquid Chromatrography-Mass Spectrometry (LC-MS) methods. The time to achieve highest plasma concentration (Tmax) is shown in the Outcome Measure Data Table.

Time frame: Before breakfast (0 hours) and 1, 3 and 6 hours after breakfast & pills on Days 1 & 7, and before breakfast on Days 8, 9 and 14.

ArmMeasureValue (MEAN)Dispersion
BSE Placebo & Garlic Oil PlaceboTmax of Sulforaphane and Its Metabolites in BloodNA hours
Garlic Oil Plus BSE PlaceboTmax of Sulforaphane and Its Metabolites in BloodNA hours
BSE Plus Garlic Oil PlaceboTmax of Sulforaphane and Its Metabolites in Blood3 hoursStandard Deviation 0
BSE & Garlic OilTmax of Sulforaphane and Its Metabolites in Blood3 hoursStandard Deviation 0
Secondary

Histone Acetylation

Histone acetylation was measured by immunoblotting the levels of acetylated histone H4K12 in the circulating peripheral blood mononuclear cells (PBMCs) of subjects who consumed either placebo, garlic oil, BSE, or BSE+garlic oil. The fold increase in acetylated histone H4K12 in the different groups is shown in the Outcome Measure Data Table.

Time frame: 6 h

Population: The data were obtained by analyzing 'representative' patient samples (n=3 per group) using immunoblotting.

ArmMeasureValue (MEAN)Dispersion
BSE Placebo & Garlic Oil PlaceboHistone Acetylation0.83 Fold changeStandard Deviation 0.15
Garlic Oil Plus BSE PlaceboHistone Acetylation1.03 Fold changeStandard Deviation 0.15
BSE Plus Garlic Oil PlaceboHistone Acetylation1.05 Fold changeStandard Deviation 0.21
BSE & Garlic OilHistone Acetylation1.20 Fold changeStandard Deviation 0.26

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026